BCL2 and metabolic dysfunction-associated steatotic liver disease: To further elucidate the regulatory effects of EQF on key targets in NAFLD, RT-qPCR and Western blot were used to assess the mRNA and protein expression levels of BCL2, CASP3, ESR1, JUN, MMP9, STAT3, and TNF.